Abstract
Derivatives of 1-(4-amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine were identified as potent and functionally active MCH-R1 antagonists. One compound with Ki = 2.3 nM demonstrated good oral bioavailability (32%) and in vivo efficacy in rats.
MeSH terms
-
Administration, Oral
-
Animals
-
Biological Availability
-
Body Weight
-
Drug Evaluation, Preclinical
-
Humans
-
Male
-
Models, Animal
-
Molecular Structure
-
Pyridines / chemistry
-
Pyridines / pharmacokinetics
-
Pyridines / pharmacology*
-
Pyrrolidines / chemistry
-
Pyrrolidines / pharmacokinetics
-
Pyrrolidines / pharmacology*
-
Rats
-
Rats, Wistar
-
Receptors, Somatostatin / antagonists & inhibitors*
-
Receptors, Somatostatin / metabolism
-
Structure-Activity Relationship
Substances
-
MCHR1 protein, rat
-
Pyridines
-
Pyrrolidines
-
Receptors, Somatostatin